The present invention relates generally to needleless fluid connection devices and more specifically to a device for repeatedly establishing a sealed connection to a conduit or a container for medical applications.
One very prevalent form of health care therapy is infusion or intravenous (“I.V.”) therapy whereby fluids possessing desired medication or other characteristics are infused into a patient over varying lengths of time. To practice this infusion therapy frequently a connection needs to be made between components for the transfer of fluid between the two components, along a fluid passageway and eventually to a patient. As an example, administration sets are widely used to administer liquids parenterally to a patient and other medical devices are connected to the administration set to provide the proper administration.
One widely used connector for making a connection between medical devices to establish a fluid passageway is a luer connection assembly. In the luer connection assembly, a male luer tip component or fitting having a frustoconical shape is inserted into a female luer component or fitting having a frustoconical shaped receiving cavity and opposing conical surfaces come into contact to form a sealed friction fit.
Until the connection is made, the passageway through each of the luer fittings and into the lumen of a component attached to the luer fitting is open to the environment. This lumen and the passageway through the luer connectors form a portion of the fluid passageway and must be sterile prior to use and then sealed against microbial ingress during use. Thus, these connection assemblies and the associated components are packaged in sterile packaging and the connections are typically made just prior to establishing fluid communication with a patient's venous system.
There are two general types of luer connection assemblies. One type is generally referred to as the luer slip where the connection is maintained by the friction fit between the male luer tip and female luer component. The other type is generally referred to as a luer lock connection whereby the male luer tip is encircled by an annular flange having a threaded internal surface. The female component includes a corresponding thread formed about the outer surface. Engaging the threaded flange to the threaded outside surface establishes the connection between the male luer tip and female component while preventing accidental disconnects.
To insure a universal luer connections among components provided by a multitude of manufacturers, luer connection assemblies are manufactured to comply with universal standards. Very important sets of standards such as ANSI and ISO standards. These standards includes standard dimensions for male slip and luer lock assemblies. Among these dimensional standards are standards which define the spacing or clearance between the annular locking flange and the male luer tip. Thus any female connection device configured to establish a connection to a standard male luer lock must be able to engage the luer tip and locking flange within this clearance or spacing.
Other standards in the ISO standards include several performance requirements for luer connections. One such requirement is that after a luer lock type connection is made, to prevent inadvertent disconnection, the luer connection should resist an axial removal force of 8 pounds and unscrewing torque less than 2.8 in/oz without disconnection. Luer connections should also hold a seal against 45 psi after a connection torque of 16 in/oz has been applied. In standard luer connections this resistance and sealing is supplied by the friction between the opposing conical surfaces.
Once a component of I.V. therapy is placed in fluid communication with the body, the fluid passageway should be sealed from the environment to prevent contamination and this passageway should also be sealed so as to not allow any leakage of bodily fluids into the environment. However, most therapies require periodic access to the fluid passageway. Because the portion of the fluid passageway through a female luer connection component is open to the environment, these components will not form a sealed connection to the fluid passageway after the fluid passageway is placed in fluid communication with the body.
In one prevalent example of intravenous therapy, fluid containing a drug in solution is injected into a primary flow of fluid from an I.V. solution container through an administration set to a catheter extending within a vein. The drug containing fluid may be injected from a syringe, secondary medication set or the like, into the set where it mixes with the flowing fluid. In another prevalent example, fluid is injected directly into or withdrawn from a catheter extending within the body. In addition the catheters are flushed periodically to maintain patency by the injection of small amounts of saline or heparin.
As can be appreciated, it is highly desirable to maintain catheters and administration sets in service as long as possible without compromising the safety of the patient. Replacement of catheters and sets is time consuming and expensive. Therefore over the period of time of use of a set or catheter there may be many connections and disconnects. For example, there may be over 100 connections and disconnects to a connection site on a catheter or set before the catheter or set is replaced. In addition a connection may be made and that connection maintained for an extended period of time before disconnection. For example a connection may be made for up to seven days of “indwell” and yet the connection should still be capable of accepting intermediate and subsequent connections and disconnects without allowing leakage to the environment.
Another highly desirable attribute of a connector is the ability for such a connector to seal against pressurized fluid found within a set or for the connector to possess a certain leak pressure in excess of a desired pressure. For example it is desirable for a connector to have a leak pressure which is in excess of 20 p.s.i. for a short period of time such as when a bolus administration of drug is injected into a set and a leak pressure excess of 6 p.s.i. of continuous pressure during infusion of medication.
In addition, a connector may be exposed to negative pressure particularly when such connector is located upstream of an inlet of an intravenous pump. Failure to prevent aspiration through a connector when the connector is exposed to negative pressure may lead to an aspiration of air and/or microbes into the fluid passageway.
Depending on the application, many other features may be desirable. Dead spaces within any connector which cannot be “flushed” should be minimized or eliminated as they may form an environment for microbial growth. Also, priming volume for the connector should be minimized.
Because intravenous therapy is practiced on a worldwide basis and millions of connection sites are used every year and the costs of components used in such therapy are a factor in the cost of therapy, any desired connector should be capable of being manufactured at high speeds and low cost. Generally the lower the number of parts making up a component, the lower the number of molds and high speed assembly devices both of which generally translate to lower capital expenditures and therefore lower costs.
On the other hand, whatever the connector configuration, it is highly desirable that the connector be capable of low defect manufacture. Even a small number of failure is generally unacceptable when a single failure may put a patient or health care provider at risk.
Moreover, it is also highly desirable that any surfaces around an inlet into a connector be able to be swabbed or otherwise disinfected. Typically unbroken or smooth surfaces facilitate swabbing and other disinfecting techniques.
As mentioned previously, although luer connectors are widely found in the medical environment such connections are generally not acceptable when many of the above described requirements need to be satisfied. This is primarily due to the fact that the opening through the luer connector is not sealed so that upon disconnection the opening and the fluid passageway are open to the environment which would pose a health hazard to the patient.
Another factor which prevents use of luer connection assemblies in administration sets or injection sites is the inability for such a connector to seal against the pressurized fluid found within a set unless that connector is sealed or connected to a mating connector. The opening in a luer fitting will obviously allow such a pressurized fluid to leak.
To allow the sealed connections and disconnects to a fluid passageway extending in a set or catheter, on many sets there are one or more injection sites having a solid resilient septum in a housing are placed on the set or catheter. A sharpened needle is used to penetrate the septum to provide a connection to the fluid passageway. Although such connections possess many of the desired characteristics for sealed connections, the sharpened needles poses a needlestick hazard.
To combat the needlestick hazard, one embodiment of a needleless systems has been developed which utilizes a resealable septum formed with a slit and compressed within a housing. These needleless systems performed quite well; however, the septum can not be penetrated with a male luer tip and thus a blunt cannula is utilized having a diameter smaller than a male luer tip. If the device to which a connection needs to be made has a luer connector, these blunt cannula are generally attached to the luer fitting. The requirement of the blunt cannula potentially increases the costs of using these types of connectors.
Another type of needleless systems use connectors which are constructed to establish a connection directly with the male luer tip whether such luer tip forms a part of a luer slip or a luer lock. However connections which are to be established with a male luer tip in a manner similar to a luer lock connection described above must be capable of fitting within the standard spacing between a luer tip and locking flange and should also meet other standards which have been set out for such connections.
Examples of these systems'connectors to establish a connection directly with a male luer tip are shown in U.S. Pat. No. 5,685,866, the disclosure of which is incorporated by reference herein. These connectors appear to all possess shortcomings which hinder widespread acceptance by medical practitioners. In general, all of these devices perform in an inferior manner when measured relative to the desirable qualities for connector devices discussed above and also in comparison to the performance standards of a injection site for a sharpened needle and resilient septum or a blunt cannula and pre-slit resilient septum
For example, several connectors utilize a resilient boot or other seal which is placed within a housing and collapsed by the introduction of a male luer tip. Upon removal of the tip, such collapsing boots must then recover to reseal the connection. Many or these boots stick in the collapsed position which leads to leaking. In addition these moving parts present an interface between the movable boot and housing into which fluid may flow and collect and such collected fluids form a fertile environment for microbial growth, and recessed surfaces and gaps are hard to disinfect. Moreover, the spikes act as flow restrictors and may impart severe turbulence to fluid as it flows through the openings in the spike. Furthermore, after withdrawal of a male luer tip the boots may not recover quickly enough to seal the entrance through the connector and the fluid passageway may be briefly exposed to the environment.
One type of such luer tip connectors has a spike within the housing which penetrates a collapsing boot. The spike has openings proximate an end adjacent the boot and form an internal passageway for the flow of fluid which is opened when the spike penetrates the collapsed boot and spreads the slit. Upon recovery, any slit or opening in the boot must reseal. However, the spike design has exhibited unsatisfactory leakage after a number of connects and disconnects which does not provide for extended use of a set or catheter.
In addition, these connectors have a multitude of parts which increases manufacturing costs and opportunities for malfunction. These designs also produce a connector having voids which cannot be flushed such that stagnant fluid may collect. Moreover, several of these device have potential passageways from voids within the housing but outside the primary fluid passageway, into the primary fluid passageway which may allow any microbial growth within the housing to enter the fluid passageway. Also the interface between the housing and boot is difficult to swab when the boot is in the uncompressed position.
A device described in U.S. Pat. No. 5,616,130, the disclosure of which is incorporated by reference herein, utilizes an elongated cam to spread open a slit in a collapsing boot, and would appear to possess several of the shortcomings of the spike and boot designs described above.
It is generally not a problem for the boot connectors to have ends which engage the male tip and locking flange on a standard luer lock. The sealing mechanism is below the end of the luer tip when the tip is engaged to the connector, thus there Is a large amount of flexibility in the configuration of the end of the connector housing which engages the male luer lock.
To overcome many of these deficiencies, needleless connections which utilize a preslit septum as one of the components were developed. These connectors establish a connection with the penetration of the slit in the septum by the luer tip. One such connector is shown and described in U.S. Pat. No. 5,578,059, the disclosure of which is incorporated by reference herein. In the disclosed valve, a resilient preslit septum is utilized to form an environmental barrier. The septum is sealingly captured or held to the housing by having a lower flange which is pinched between a retainer and housing. It appears that the radially extending portion having a slit is maintained in position by the column strength of an outer axially extending cylindrical portion extending upward from the lower flange. However the septum appears not to be capable of sealing against the pressurized fluid found in a set. Thus the valve uses a second lower check type valve to seal against the pressure.
To satisfy ISO dimensional standards and torque removal resistance standards the outer portion of the retainer is formed with a tapered threads so that the connection to a luer lock's straight thread design is similar to a standard NPTF/NPSI connection. The tapered thread design extends over the end of the housing that engages the threads on a male luer lock. Such a thread design may produce too rapid an increase in engaging force during the connection which may lead to a lock up of the luer lock to the connector.
Such a device suffers from several other drawbacks. The valve includes a number of components to make up the housing, the environmental valve and check valve, and this high number of components increases manufacturing costs. In addition, maintaining the septum in position by the column strength of the axially extending portion of the septum forces that portion to have a relatively large thickness. Thus for the septum, the axially extending wall and surrounding housing to fit within the clearance between the luer tip and the locking flange upon penetration of a male luer tip to a desired depth, the housing must be thinned. Such a thinned housing may fracture upon repeated connections and disconnects.
A second connector is described in U.S. Pat. No. 5,533,708, the disclosure of which is incorporated by reference herein. This connector also utilizes a preslit septum which is supported on an axially extending column having sufficient thickness to support the septum upon introduction of the male luer tip. The further provide sufficient column strength the axially extending portion is also formed with a specific tapered shape including a thickened lower portion. To seal the slit during introduction and removal of a luer tip, the underside of the pre-slit radial portion of the septum is formed with biasing ribs.
This connector also uses a retainer which pinches a lower radial flange to sealingly fix the septum to the housing. Thus the connector includes three separate pieces. In addition the thickened axially extending portion of the septum forces the retainer to be thinned such that to presumably supply strength to the retainer the stated preferred material for the retainer is metal which increases manufacturing costs. In addition it is believed that such valves will not exhibit satisfactory leak pressure after long periods of indwell, likely due to compression set of the septum material due to a perceived high level of compression of the septum material between the tip and retainer.
To supply the necessary unscrewing resistance, the retainer is tapered outward proximate the end to establish a frictional engagement with the threads on a male luer lock.
Another feature which is desired by some users, is that a connector not siphon fluid from an attached tubing or catheter into the connector upon removal of the luer tip as this may cause fluid to flow into the other end of the catheter which it is felt may lead to blockage of the tubing. In addition it is desired that a connector is provided which actually expels fluid from the connector upon removal of the luer tip and preferably expels such fluid in a controlled manner.
Therefore, it is a main object of the invention to overcome those disadvantages of the prior art which prevent widespread acceptance of needleless valves which do not require a blunt cannula.
There are other secondary objects, one or more if satisfied may promote market acceptance but satisfaction of each may not be necessary. One object of the present invention is to provide a needless connector fitting which may be actuated by a male luer tip without using a sharpened needle or an adapter such as a blunt cannula or the like. A related object is to provide a connector which may engage a standard luer lock fitting. A further related object is to provide such a connector which may be coupled to a standard male luer lock and complies as much as possible with ISO and ANSI standards for luer connectors
Another object of the present invention is to provide a connector which possess sufficient strength to avoid cracking or fracture.
It is a further object of the present invention to provide a connector device which utilizes a minimum number of parts and therefore minimizes opportunity for malfunction.
It is another object of the present invention to provide a connector device which is capable of providing for a large number of connections and disconnects while maintaining the ability to seal against fluids under pressures typically found in an administration set. A related object is to provide such a connector which is capable of providing a minimum of 100 connects and disconnects without compromising the performance.
It is yet a further object of the present invention to provide a connector which upon a disconnection, maintains a leak pressure of 6 psi. constant pressure and 20 psi transient pressure after 4 days of indwell.
It is a further object of the present invention to provide a connector which is capable of high speed manufacturing. It is a related object of the present invention to provide a connector which may be manufactured with a very low number of potential defects.
It is yet another object of the present invention to provide a connector which minimizes voids which cannot be flushed in which stagnant fluid can collect to form a media for microbial growth. It is a related object of the present invention to provide a connector which forms a sealed fluid path such that a minimum number of microbes enter the fluid path during operation using aseptic techniques. It is a further related object to provide a connector which requires a low priming volume.
It is still a further object of the present invention to provide a connector which minimizes or eliminates flow restrictions for the flow of fluid through the connector. In addition it is an object to provide a connector having smooth unbroken surfaces about any inlet to facilitate aseptic techniques.
It is yet another object of the present invention to provide a connector which forms a continuous closed system which seals the fluid passageway from the environment during and after insertion of a male luer tip and instantaneously after withdrawal of the luer tip.
It is a further object of the present invention to provide a connector which does not siphon fluid into the connector from an attached medical device upon removal of a luer tip. A related object is to provide a connector which provides a flow of fluid from the connector during and possibly after removal of the luer tip.
The above main object is satisfied by connector utilizing a resealable valve having an opening extending through at least a portion of the valve. The valve is resiliently restrained relative to a housing with the valve and housing configured to accept a penetrating member having a tip which penetrates the valve through the opening.
One or more of the secondary objects are satisfied by a valve uniquely configured to seal against pressures typically found in fluid passageways which are in fluid communication with the body. Preferably the resealable valve is a septum and the septum and housing are uniquely configured to accept male luer tips. In one embodiment, the septum includes an upper generally disk shaped upper portion covering an opening defined by the housing and a portion extending downward from the upper portion with the valve opening extending through both the upper and lower portion.
The upper portion of the valve is resiliently retained relative to the housing by integral attachment with an annular skirt and the skirt may be attached to the interior surface of the housing in a first embodiment and surrounding and attached to an exterior surface of the housing in a second embodiment.
The following description is not intended to limit the claimed invention to the described embodiments and the disclosed combination of features in the various embodiments might not be absolutely necessary for the inventive solution.
Referring to
Referring to
Referring also to
The central portion 34 of the septum 28 has a generally disk shaped upper portion 38 and a lower portion 40 extending axially downward within the passageway. A resealable opening 44, such as a slit 46 extends downward preferably through both the upper portion 38 and lower portion 40. It is anticipated that the opening 44 may be formed so that initially the opening may extend only through a portion of one or both of the upper and lower portions 38, 40; however, extending a penetrating member 12 completely through the septum 28 will force the opening to also extend completely through the septum 28. Preferably the opening 44 is configured in such a manner such that when the penetrating member 12 extends completely through the septum 28 the upper and lower portions 38, 40 are elastically stretched about the penetrating member to seal against leakage through the interface between the penetrating member and the septum.
The slit length in the horizontal direction is preferably shorter than one half the circumference of the tip end of the luer tip 18.
As shown in
Referring back to
Referring to
In
Referring briefly back to
When the tip 18 is inserted into the connector 10 to the desired depth D, there is a limited amount of annular space between the housing 26 and tip into which portions of the septum 28 may be displaced; however, the septum must be configured and sized to seal before, during and after extension of the penetrating member 12 through the opening 44 to form a closed system.
Referring to
However, even if a luer tip 18, with its much wider diameter relative to the housing opening than the blunt cannula relative to the corresponding housing opening, could be forced through the slit in such a septum, there is little room in the radial direction to provide a receiving space for the displaced mass of the septum. Thus, the necessary insertion force would likely be too much for most medical practitioners. However, it has been found that thinning the septum 28 to allow displacement and accommodation of the septum between the tip and housing while maintaining the same radial compression does not provide the septum with the ability to seal against a pressure found in fluid passageways i.e. “leak pressure”, found during intravenous therapy. Unexpectedly, increasing the radial compression of the thinned septum does not appear to provide a corresponding rate of increase in the leak pressure of the connector 10.
Forming the septum 28 with a thinned upper portion 38 and a downwardly extending lower portion 40 and providing that the opening 44 extends downward through the lower portion 40 in addition to the upper portion 38 greatly increases the leak pressure without requiring a corresponding large increase in septum thickness or compression. Moreover, tests have shown that the length “L1” (
The first embodiment's configuration of a unique combination with a predetermined length L1 of the lower portion 40, thickness and compression of the upper portion 38 gives the connector 10 a leak pressure of more than 20 p.s.i while presenting an acceptable insert force. Other features of the configuration of the first embodiment is the ability to provide a reseal, after multiple insertions of the luer tip and long periods of luer tip indwell, against a pressure of 6 p.s.i.
As an example, in the first embodiment, forming the septum with the upper portion 38 having a thickness of 0.040 inches and a 3.5% radial compression or greater and the lower portion 40 having a length L1 of about 0.080 inches (giving rise to a opening length of 0.125 inches) yields a connector 10 which may accept the luer tip 18 to the desired depth D while maintain a leak pressure in excess of 20 p.s.i.
Referring in particular to
Referring back to
Referring to
Referring again to
At the juncture between the central portion 34 and skirt 52 a sharp corner is formed which establishes a hinge point 78. The hinge point 78 which extends about the housing for the entire circumference of the opening 32 also facilitates the flexing and deformation of the septum 28 during insertion of the tip 18.
In an embodiment, the septum 28 is formed of a elastic, resilient material provided by the West Company of Lionville, Pa. It is anticipated that lubricating the septum 28 should facilitate insertion of the luer tip 18. Such lubrication may be applied while forming the slit or by other means such as incorporating the lubrication into the septum material or by applying lubricious coatings to the top surface. In a second embodiment, the septum 28 may be formed of a similar material, such as chlorinated polyisoprene produced by Lexington Medical of Rock Hill, S.C. In addition, the slit may be lubricated after assembly of the housing and septum using silicon oil produced by Dow Corning of Midland, Mich. The housing 26 is rigid and preferably formed of DN003 from Eastar of Kingsport, Tenn.
Although the housing 26 is shown as forming a luer connection 84 at a lower end, the housing may also be formed as a part of any device into which is it desirable to establish a sealed connection such as the injection arm of a Y-site 86 (
Referring to
Preferably the housing 26 is molded as a single piece utilizing molds with a large number of molding cavities to facilitate high speed manufacturing operation. Similarly the valve member 27 is preferably formed as a single piece in a high speed molding operation, and the shape of the lower portion 40 is particularly suited to register the valve member 27 in a desired orientation for fashioning an opening 44 therein.
Referring to
The connector 100 includes a housing 102 and an elastic and resilient resealable valve member 104 disposed at an upper end 106 of the housing. The valve member 104 includes the central portion 34 and lower portion 44; however the valve member 104, preferably a septum 105, also includes an annular skirt portion 108 which extends about and surrounds an upper portion 110 of the housing 102 adjacent the upper end 106. Preferably the skirt 108 is bonded to the exterior surface 112 in a specified manner to attach the valve 104 to the housing 102 and elastically restrain the central portion 34 during insertion of the luer tip 18 (
Referring to
The central portion 34 is configured such that the upper edge portion 106 applies a 6 to 7% compression on the central portion. To provide adequate reseal, it is desired that the upper portion 40 of the valve 102 form a thickness of 0.60 to 0.50 inches and the lower portion define a length L3 of 0.080 inches.
Preferably the lower portion 40 is formed with a width “W2” of approximately 0.060 inches and a length “L4” of about 0.165 inches. The annular skirt 108 is formed with a thickness of about 0.010 inches. The top surface 70 of the septum 28 is slightly concave to lessen the amount of material being forced into the housing 102 upon insertion of the tip 18 (
At the interface between the central portion 34 and upper end 106 of the housing 102, the valve member 104 forms a sharp corner and thereby forms a hinge point 78. Similar to the first embodiment 10, lower portion 40 is spaced from the housing to form a gap 77.
It has been found that bonding an upper landing 117 defined by an upper edge 116 to the valve 104 and about the entire circumference of the of the upper edge is important in the ability of the connector 100 to maintain a satisfactory leak pressure and increasingly important to maintain the leak pressure after 100 or more connections and disconnects. The bonding also anchors the septum 28 to the upper edge and prevents a rubbing between the septum 28 and upper edge 116 as the septum is elastically stretched during insertion of the tip 18.
Bonding between the exterior surface 112 and the inner surface of the skirt 108 is also important, but migration of any bonding agent to the interface between the central portion 34 and housing 102 should be minimized. If adhesive collects in the interface about the septum 28 and interior surface 119 cracking of the housing 102 or compression set of the septum 28 with corresponding leakage after long periods of indwell may result.
One preferred method of applying bonding agent to the housing 102 such that the upper landing 117 and exterior surface 112 receive such agent while minimizing migration to the interior of the housing is minimized is by placing the housing 102 is a vertical position with the upper edge 116 facing downwards. Bonding agent is applied, preferably by injection, to the exterior surface 112 and gravity causes the agent to flow down and wet the landing 117. Gravity also hinders any migration of the bonding agent into the interior surface of the housing 102. A further preferred step includes inserting the upper end portion 110 of the housing 102 into a chamber (not shown) and applying a negative air pressure below the housing 102 such that air flows downward along the housing which also hinders migration of the bonding agent upwards into the interior of the housing.
It has been found that a UV curing adhesive, such as Loctite 3011, 3311 and 3301 from Loctite Corporation of Rocky Hill, Conn. may be utilized as a suitable bonding agent for any of the connectors 10, 100, 200.
The bonding agent should be cured for a sufficiently long period of time.
Referring to
Referring also to
To facilitate a releasable engagement of the penetrating member 12 to the connector 100 and to minimize or eliminate any shredding of the skirt 108, the skirt 108 may be provided with a thickness such that there is minimal interference between the skirt 108 and the inner edge surfaces 64a of the threads 64 on the locking flange 20. However the smaller the diameter defined by the skirt 108 with a given skirt thickness and housing thickness, the smaller the volume which must accommodate both the penetrating member 12 and valve 104 upon insertion of the member 12.
It has been found that providing a housing 102 with the upper portion 110 having a external diameter of 0.25 inches and defining an opening 144 with a diameter of 0.22 is desired to provide the proper clearance between the skirt 108 and locking flange 20 of an ISO standard luer connection and yet also provide a housing with sufficient wall strength to resist fracture and provide sufficient space for the displaced septum 28 and luer tip 18 when the luer tip is inserted into the housing 102.
Referring to
As illustrated in
Referring to
The needless connector 130 is shown as generally corresponding to the second embodiment of the needless connector 100, however, the resealable valve member 140 and housing 138 proximate the valve member may be shaped to correspond to the housing and valve member of either the first embodiment 10, second embodiment 100 or the later described embodiment 200.
As can be appreciated, once the luer tip 18 penetrates the valve member 140, the passageway 66 in the tip is placed directly in fluid communication with that portion of the primary flow path 132 extending into the exit section 136 without any intermediate valves so any flow restriction is reduced.
Referring to
In particular, the housing 202 indudes the upper portion 110 having the surface 124 of a generally constant outside diameter over which the skirt 108 extends. A middle portion 206 extends downward from the upper portion 116 and a lower portion 208 extends downward from the middle portion. The lower portion 208 preferably defines a generally constant diameter greater than the diameter defined by the upper portion 116. The middle portion 206 is formed to provide a transition from the upper portion 116 to the relatively wider lower portion 208. Preferably the middle portion 206 is frustoconically shaped.
Referring to
Utilization of an upper portion with a surrounding skirt 108 defining a diameter approximately that of the standard major diameter of threads 64, a frustoconical middle portion 206 defining a diameter increasing from a diameter less than the diameter defined by the skirt 108 to the diameter of the lower portion 208 and the lower portion defining a diameter greater than the minor diameter of the internal threads 64 imparts a feel to the user similar to connecting to a standard female luer connection.
When the user first inserts the locking flange 20 over the connector 200, slipping the flange over the upper portion 116 and surrounding skirt 108 promotes centering of the luer tip 18 relative to the connector 200 and minimizes the opportunity for cross threading. As the tip and flange 20 continue over the connector 200, the threads 64 then engage the threads 210 and the connector 200 must then be rotated relative to the flange 20 to threadingly engage the flange 20 to the connector 200.
During rotation, the tip 18 extends through the opening 44 and rubs against the valve 104 however such contact supplies very little resistance to turning. The threads 64 engage the middle portion 206 and a sliding frictional engagement begins and the required torque to advance or unthread slowly increases as the tip ;is rotatably advanced. The threads 64 then engage the lower portion 208 having a constant diameter which slows down the rate or increase in the removal torque before an unacceptable removal torque is achieved which may cause the locking flange 20 to lock up on the connector.
In addition male luer locks 13 may be made of many different types of materials which range in stiffness. It is important that the connection of the connector 200 to the luer lock not place such a stress on the locking flange 20 which may fracture the flange. The use of the lower portion 208 with a constant diameter also accommodates luer locks of various materials while preventing overstressing of the locking flange 20.
Thus five example embodiments of a needleless connector have been described. It is believed that the embodiments provide features which solve many of the drawbacks which have hindered widespread acceptance of such needleless connectors relative to the market acceptance of the type of connectors which must be pierced with a sharp needle or blunt cannula.
Referring to
Referring briefly to
A valve element, generally indicated at 320, provides at least one seal against pressurized fluid within an exit passageway 324 formed by portions of the extension 308 and housing 304. The exit passageway 324 is in fluid communication with a device 326 in fluid communication with a body. The device 326 may include a catheter or an I.V. administration set. If the connector 300 is for providing a resealable connection with an I.V. administration set, the housing 304 will preferably form a portion of a Y-site.
The valve 320 includes a pincher portion 328 which pinchingly deforms the extension 308 to seal against leak pressure found in the exit passageway 324. The pincher portion 328 is attached to the housing 304 by fixedly clamping a peripheral edge 330 between an upper housing piece 334 and a lower housing piece 336 which are bonded together to form the housing 304.
The connector 300 also includes an extension collapsing element 338 which contacts and partially collapses a portion of the extension 308 after and possibly during the sealing of the extension by the valve 320. The partial collapsing produces an expelling of fluid from the exit passageway 324 after the sealing of the extension by the valve 320.
Referring also to
To place the pincher portion 328 in a better position for contact and activation by the luer tip 18, the valve 320 may be formed with a central portion 344 offset upward of the peripheral edge 330. The legs 340 are attached to this central portion 344; however, the legs may be attached to other parts of the housing 304.
To facilitate sealingly attaching the extension 308 to the housing 306, the lower piece 336 forms a radial lip 346, and the lower end of the extension is adhesively attached to the housing 305 proximate this lip. To hinder buckling of the extension 308 when the luer tip 18 forces the central part of the septum 302 downward, the extension may be stretched during assembly and attached to the housing in the stretched configuration.
Referring briefly to
The attachment of the extension 308 to the upper portion 306 of the septum 302 and the housing 304 may help support the upper portion 306 against leaking due to pressurized fluid in the conduit 314. The extension 308 also prevents fluids from flowing into the housing outside of the extension an into areas which may be difficult to flush during use of the connector 300.
The septum 302 may also include a lower portion (not shown) similar to lower portion 40 (
Referring to
The septum 202 is attached to the top end 212 of housing 214 to seal an opening 216 formed by the top end. The housing forms an internal chamber 218 and a radially extending valve seat 220. A lower end 224 of the housing 214 is adapted to form a luer connection with the device 326 which is adapted to be placed in fluid communication with the body.
The septum 202 also includes a downward depending generally tubular extension 228 which extends to a point in reasonably close proximity with the valve seat 220. Sealingly attached to a lower end 230 of the extension 228 is a radial sealing flange 234. The flange 234 extends radially outward and forms a peripheral edge 236 which sealingly attaches to the housing 214. The septum 202 and flange 234 cooperate to prevent fluid flowing through a passageway 238 formed within the extension 228 from flowing into the chamber 218 outside of the extension and between the flange 234 and top end 240 of the housing.
Disposed within the housing 214 and about an outlet 240 of the chamber 218 is a valve 248. The valve 248 is uniquely configured to provide less fluid flow resistance when low pressure fluid is within the passageway 238 and high fluid flow resistance when high pressure fluid is within the passageway. Referring to
The valve 248 includes a set of downward depending legs 256 which contact a radial ledge 258 formed by the housing 214. The legs 256 are configured to support the flange 250 so that the peripheral edge 236 is spaced from the valve seat 220. Thus fluid may flow from the passageway 238 around the peripheral edge 254 and out an outlet 260 for the connector 200. The legs 256 are also configured to flex when fluid over a certain pressure is injected through the opening 210 and into the passageway 238 (as particularly illustrated in
The valve 248 also includes a capillary tube 262, preferably of a small diameter and constructed of metal, glass or the like, which extends through the flange 250 to form a passageway for a small flow of fluid from the passageway 238 into the outlet 260. The tube 262 is preferably sized so that the flow of fluid through the passageway is enough to maintain a KVO or keep vein open flow of fluid to the device 326.
Also when the luer tip 18 is inserted through the opening 210 and fluid is injected into the extension 228, the extension elastically expands in a radial direction to form a reservoir 268. The resiliency of the extension 228 maintains the fluid at a pressure sufficient to keep the flange 250 sealed against the seat 220 so that fluid only flows through the capillary tube 262. When sufficient fluid flows out of the reservoir 268 so that the extension 228 is in an almost deflated configuration, the pressure of the fluid in the passageway 238 drops to a level whereby the legs 256 straighten and the flange 250 separates from the valve seat 220 to allow much greater flow into the outlet 260.
Therefore it may be seen that by varying the configuration and material of the legs 256 in conjunction with the material of the extension 228, the pressure at which the valve 248 opens may be altered.
Referring to
A lower edge 417 of the lower portion 410 is sealingly engaged to a housing 418, preferably rigid, of the connector 400. In particular the housing 418 includes an upper portion 420 similar in configuration to the upper end of connector (
The lower edge 417 of the lower portion 410 extends about and is attached to an upwardly extending nipple 428. A collar 430 formed by the lower portion 424 of the housing 418 extends about the lower edge 417 and clamps the lower edge to the nipple 428. The lower portion 424 and upper portion 420 are attached to each other preferably by sonic welding or other appropriate type.
Referring to
Referring to
However connector 450 also includes a collapsing member 452, preferably a split collar 454 which is disposed in the void 456 between the lower portion 410 of the valve 402 and the upper portion 420 of the housing 418. The collapsing member 452 includes opposing inward landings 458 disposed on opposite sides of the lower portion 410 and engaging the lower portion to collapse the lower portion thereby lowering the volume of a chamber 460 defined by the lower portion. The landings 458 are resiliently supported by legs 464 angled in an outward direction. The collapsing member 452 may be composed of metal or other material which provides the desired resiliency in the legs 464.
Upon insertion of the luer tip 18, the luer tip 18 forces the landings 458 outward, bending the legs 464 so that the legs become generally aligned with the landings 458 and the lower portion 410 below the tip 18 defines the chamber 460′. Fluid may then be injected into the connector. Upon removal of the tip 18, the resiliency of the lower portion 410 will cause the lower portion to seek to assume the conical shape; however, the legs 464 will force the landings 458 inward to further collapse the lower portion such that the chamber 460 defined by the lower portion has a smaller volume than chamber 460′. Thus siphoning of fluid into the chamber 460 upon removal of the tip 18 is avoided and a slight volume of fluid is expelled from the chamber 460′ through the lower end 426 upon the tip removal.
It will be understood that the embodiments of the present invention which have been described are illustrative of some of the applications of the principles of the present invention. Various modifications may be made by those skilled in the art without departing from the true spirit and scope of the invention.
This application is a continuation of application Ser. No. 09/081728, filed May 20, 1998 now U.S. Pat. No. 5,957,898, issued Sep. 28, 1999, claims the benefit of U.S. Provisional Application No. 60/047,161, filed May 20, 1997.
Number | Name | Date | Kind |
---|---|---|---|
2950257 | Hibbs et al. | Aug 1960 | A |
3853127 | Spademan | Dec 1974 | A |
3898988 | Morgan | Aug 1975 | A |
3968508 | Ikeuchi | Jul 1976 | A |
3974832 | Kruck | Aug 1976 | A |
3976063 | Hennemann et al. | Aug 1976 | A |
3977400 | Moorehead | Aug 1976 | A |
3977403 | Patel | Aug 1976 | A |
3986508 | Barrington | Oct 1976 | A |
3994293 | Ferro | Nov 1976 | A |
3994516 | Fredd | Nov 1976 | A |
4000739 | Stevens | Jan 1977 | A |
4006744 | Steer | Feb 1977 | A |
4019512 | Tenczar | Apr 1977 | A |
4040421 | Young | Aug 1977 | A |
4063555 | Ulinder | Dec 1977 | A |
4076285 | Martinez | Feb 1978 | A |
4080965 | Phillips | Mar 1978 | A |
4084606 | Mittleman | Apr 1978 | A |
4105187 | Huber | Aug 1978 | A |
4105500 | Libman et al. | Aug 1978 | A |
4106491 | Guerra | Aug 1978 | A |
4121585 | Becker, Jr. | Oct 1978 | A |
4128098 | Bloom et al. | Dec 1978 | A |
4133312 | Burd | Jan 1979 | A |
4143853 | Abramson | Mar 1979 | A |
4143858 | Schmidt, III et al. | Mar 1979 | A |
4149535 | Volder | Apr 1979 | A |
4161949 | Thanawalla | Jul 1979 | A |
4177809 | Moorehead | Dec 1979 | A |
4177814 | Knepshield et al. | Dec 1979 | A |
4187846 | Lolachi et al. | Feb 1980 | A |
4192304 | Millet | Mar 1980 | A |
4197848 | Garrett et al. | Apr 1980 | A |
4200096 | Charvin | Apr 1980 | A |
4201208 | Cambio, Jr. | May 1980 | A |
4219021 | Fink | Aug 1980 | A |
4219912 | Adams | Sep 1980 | A |
4240411 | Hosono | Dec 1980 | A |
4252122 | Halvorsen | Feb 1981 | A |
4261357 | Kontos | Apr 1981 | A |
4266815 | Cross | May 1981 | A |
4294250 | Dennehey | Oct 1981 | A |
4324239 | Gordon et al. | Apr 1982 | A |
4326569 | Vaillancourt | Apr 1982 | A |
4328802 | Curley et al. | May 1982 | A |
4332333 | Linsey | Jun 1982 | A |
4334551 | Pfister | Jun 1982 | A |
4338933 | Bayard et al. | Jul 1982 | A |
4341224 | Stevens | Jul 1982 | A |
4341239 | Atkinson | Jul 1982 | A |
4360024 | Wallace | Nov 1982 | A |
4387879 | Tauschinski | Jun 1983 | A |
4392856 | Lichtenstein | Jul 1983 | A |
4411662 | Pearson | Oct 1983 | A |
4421123 | Percarpio | Dec 1983 | A |
4421296 | Stephens | Dec 1983 | A |
4425919 | Alston, Jr. et al. | Jan 1984 | A |
4429856 | Jackson | Feb 1984 | A |
4432755 | Pearson | Feb 1984 | A |
4432759 | Gross et al. | Feb 1984 | A |
4432765 | Oscarsson | Feb 1984 | A |
4436125 | Blenkush | Mar 1984 | A |
4436519 | O'Neill | Mar 1984 | A |
4439193 | Larkin | Mar 1984 | A |
4443219 | Meisch et al. | Apr 1984 | A |
4445893 | Bodicky | May 1984 | A |
4449693 | Gereg | May 1984 | A |
4457548 | Muto | Jul 1984 | A |
4457749 | Bellotti et al. | Jul 1984 | A |
4457753 | Pastrone | Jul 1984 | A |
4496348 | Genese et al. | Jan 1985 | A |
4508367 | Orepoulos et al. | Apr 1985 | A |
4511359 | Vaillancourt | Apr 1985 | A |
4512766 | Vailancourt | Apr 1985 | A |
4526572 | Donnan et al. | Jul 1985 | A |
4534758 | Akers et al. | Aug 1985 | A |
4535818 | Duncan et al. | Aug 1985 | A |
4535819 | Atkinson et al. | Aug 1985 | A |
4535820 | Raines | Aug 1985 | A |
4547193 | Rydell | Oct 1985 | A |
4566493 | Edwards et al. | Jan 1986 | A |
4568081 | Martin | Feb 1986 | A |
4568336 | Cooper | Feb 1986 | A |
4573993 | Hoag et al. | Mar 1986 | A |
4592356 | Gutierrez | Jun 1986 | A |
4601703 | Herlitze | Jul 1986 | A |
4607671 | Aalto et al. | Aug 1986 | A |
4610276 | Paradis et al. | Sep 1986 | A |
4610469 | Wolff-Mooij | Sep 1986 | A |
4610665 | Matsumoto et al. | Sep 1986 | A |
4610674 | Suzuki et al. | Sep 1986 | A |
4612960 | Edwards et al. | Sep 1986 | A |
4615693 | Paradis et al. | Oct 1986 | A |
4617012 | Vaillancourt | Oct 1986 | A |
4623068 | Brown et al. | Nov 1986 | A |
4629159 | Wellenstam | Dec 1986 | A |
4629450 | Suzuki et al. | Dec 1986 | A |
4645494 | Lee et al. | Feb 1987 | A |
4649904 | Krauter et al. | Mar 1987 | A |
4655752 | Honkanen et al. | Apr 1987 | A |
4673393 | Suzuki et al. | Jun 1987 | A |
4673394 | Fenton, Jr. et al. | Jun 1987 | A |
4673400 | Martin | Jun 1987 | A |
4683916 | Raines | Aug 1987 | A |
4706487 | Bandou et al. | Nov 1987 | A |
4725267 | Vaillancourt | Feb 1988 | A |
4728075 | Paradis | Mar 1988 | A |
4745950 | Mathieu | May 1988 | A |
4752287 | Kurtz et al. | Jun 1988 | A |
4752292 | Lopez et al. | Jun 1988 | A |
4758225 | Cox et al. | Jul 1988 | A |
4759756 | Forman et al. | Jul 1988 | A |
4765588 | Atkinson | Aug 1988 | A |
4768568 | Fournier et al. | Sep 1988 | A |
4775369 | Schwartz | Oct 1988 | A |
4781702 | Herrli | Nov 1988 | A |
4786281 | Valentini et al. | Nov 1988 | A |
4804015 | Albinsson | Feb 1989 | A |
4809679 | Shimonaka et al. | Mar 1989 | A |
4810241 | Rogers | Mar 1989 | A |
4823833 | Hogan et al. | Apr 1989 | A |
4827973 | Boehmer | May 1989 | A |
4832214 | Schrader et al. | May 1989 | A |
4834152 | Howson et al. | May 1989 | A |
4834664 | Lin | May 1989 | A |
4834719 | Arenas | May 1989 | A |
4838855 | Lynn | Jun 1989 | A |
4838873 | Lanskron et al. | Jun 1989 | A |
4842591 | Luther | Jun 1989 | A |
4846809 | Sims | Jul 1989 | A |
4850975 | Furukawa | Jul 1989 | A |
4856533 | Anraku et al. | Aug 1989 | A |
4857062 | Russell | Aug 1989 | A |
4863201 | Carstens | Sep 1989 | A |
4865583 | Tu | Sep 1989 | A |
4871356 | Haindl et al. | Oct 1989 | A |
4874377 | Newgard et al. | Oct 1989 | A |
4878897 | Katzin | Nov 1989 | A |
4886507 | Patton et al. | Dec 1989 | A |
4895346 | Steigerwald | Jan 1990 | A |
4908018 | Thomsen | Mar 1990 | A |
4909798 | Fleischhacker et al. | Mar 1990 | A |
4915687 | Sivert | Apr 1990 | A |
4917668 | Haindl | Apr 1990 | A |
4928212 | Benavides | May 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4943896 | Johnson | Jul 1990 | A |
4944732 | Russo | Jul 1990 | A |
4950260 | Bonaldo | Aug 1990 | A |
4954149 | Fullemann | Sep 1990 | A |
4960412 | Fink | Oct 1990 | A |
4964855 | Todd et al. | Oct 1990 | A |
4966588 | Raymann et al. | Oct 1990 | A |
4969879 | Lichte | Nov 1990 | A |
4969883 | Gilbert et al. | Nov 1990 | A |
4981469 | Whitehouse et al. | Jan 1991 | A |
4984829 | Saigo et al. | Jan 1991 | A |
4986310 | Bailey et al. | Jan 1991 | A |
4998713 | Vaillancourt | Mar 1991 | A |
4998921 | Vickroy et al. | Mar 1991 | A |
4998927 | Vaillancourt | Mar 1991 | A |
5000745 | Guest et al. | Mar 1991 | A |
5006114 | Rogers et al. | Apr 1991 | A |
5006118 | Yule | Apr 1991 | A |
5009391 | Steigerwald | Apr 1991 | A |
5009490 | Kouno et al. | Apr 1991 | A |
5010925 | Atkinson et al. | Apr 1991 | A |
5018532 | Etheredge, III | May 1991 | A |
5041087 | Loo et al. | Aug 1991 | A |
5041095 | Littrell | Aug 1991 | A |
5041097 | Johnson | Aug 1991 | A |
5046456 | Heymann et al. | Sep 1991 | A |
5049128 | Duquette | Sep 1991 | A |
5057092 | Webster, Jr. | Oct 1991 | A |
5059186 | Yamamoto et al. | Oct 1991 | A |
5060812 | Ogle, II | Oct 1991 | A |
5061253 | Yoshida | Oct 1991 | A |
5061738 | Solomon et al. | Oct 1991 | A |
5064416 | Newgard et al. | Nov 1991 | A |
5065783 | Ogle, II | Nov 1991 | A |
5069225 | Okamura | Dec 1991 | A |
5069424 | Dennany, Jr. et al. | Dec 1991 | A |
5070905 | Paradis | Dec 1991 | A |
5071404 | Larkin et al. | Dec 1991 | A |
5078699 | Haber et al. | Jan 1992 | A |
5080654 | Picha et al. | Jan 1992 | A |
5085645 | Purdy et al. | Feb 1992 | A |
5088984 | Fields | Feb 1992 | A |
5092840 | Healy | Mar 1992 | A |
5092857 | Fleischhacker | Mar 1992 | A |
5098405 | Peterson et al. | Mar 1992 | A |
5099878 | Boehmer | Mar 1992 | A |
5100394 | Dudar et al. | Mar 1992 | A |
5103854 | Bailey | Apr 1992 | A |
5104379 | Nakamura et al. | Apr 1992 | A |
5104389 | Deem et al. | Apr 1992 | A |
5108380 | Herlitze et al. | Apr 1992 | A |
5114408 | Fleischhaker et al. | May 1992 | A |
5122123 | Vaillancourt | Jun 1992 | A |
5127904 | Loo et al. | Jul 1992 | A |
5129426 | Boehmer | Jul 1992 | A |
5134489 | Sauer | Jul 1992 | A |
5135489 | Jepson et al. | Aug 1992 | A |
5137527 | Miller et al. | Aug 1992 | A |
5139483 | Ryan | Aug 1992 | A |
5147333 | Raines | Sep 1992 | A |
5154703 | Banaldo | Oct 1992 | A |
5158554 | Jepson et al. | Oct 1992 | A |
5163922 | McElveen, Jr. et al. | Nov 1992 | A |
5167637 | Okada et al. | Dec 1992 | A |
5167642 | Fowles | Dec 1992 | A |
5167648 | Jepson et al. | Dec 1992 | A |
5171234 | Jepson et al. | Dec 1992 | A |
5178607 | Lynn et al. | Jan 1993 | A |
5179174 | Elton | Jan 1993 | A |
5184652 | Fan | Feb 1993 | A |
5188620 | Jepson et al. | Feb 1993 | A |
5190067 | Paradis et al. | Mar 1993 | A |
5195980 | Catlin | Mar 1993 | A |
5199948 | McPhee | Apr 1993 | A |
5201725 | Kling | Apr 1993 | A |
5203775 | Frank et al. | Apr 1993 | A |
5207656 | Kranys | May 1993 | A |
5211634 | Vaillancourt | May 1993 | A |
5211638 | Dudar et al. | May 1993 | A |
5215537 | Lynn et al. | Jun 1993 | A |
5215538 | Larkin | Jun 1993 | A |
5230706 | Duquette | Jul 1993 | A |
5234410 | Graham et al. | Aug 1993 | A |
5242393 | Brimhall et al. | Sep 1993 | A |
5242423 | Goodsir et al. | Sep 1993 | A |
5242432 | DeFrank | Sep 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5250033 | Evans et al. | Oct 1993 | A |
5251873 | Atkinson et al. | Oct 1993 | A |
5256155 | Yerlikaya et al. | Oct 1993 | A |
5261459 | Atkinson et al. | Nov 1993 | A |
5269763 | Boehmer et al. | Dec 1993 | A |
5269771 | Thomas et al. | Dec 1993 | A |
5273533 | Bonaldo | Dec 1993 | A |
5279571 | Larkin | Jan 1994 | A |
5280876 | Atkins | Jan 1994 | A |
5289849 | Paradis | Mar 1994 | A |
5290254 | Vaillancourt | Mar 1994 | A |
5295657 | Atkinson | Mar 1994 | A |
5295658 | Atkinson et al. | Mar 1994 | A |
5296771 | Sakuma et al. | Mar 1994 | A |
5301707 | Hofsteenge | Apr 1994 | A |
5306243 | Bonaldo | Apr 1994 | A |
5312362 | Pfolsgraf et al. | May 1994 | A |
5312377 | Dalton | May 1994 | A |
5330435 | Vaillancourt | Jul 1994 | A |
5330437 | Durman | Jul 1994 | A |
5336192 | Palestrant | Aug 1994 | A |
5344414 | Lopez et al. | Sep 1994 | A |
5349984 | Weinheimer et al. | Sep 1994 | A |
5353837 | Faust | Oct 1994 | A |
5360413 | Leason et al. | Nov 1994 | A |
5368801 | Valliancourt | Nov 1994 | A |
5370636 | Von Witzleben | Dec 1994 | A |
5380306 | Brinon | Jan 1995 | A |
5390898 | Smedley et al. | Feb 1995 | A |
5395348 | Ryan | Mar 1995 | A |
5401245 | Haining | Mar 1995 | A |
5402982 | Atkinson et al. | Apr 1995 | A |
5409125 | Kimber et al. | Apr 1995 | A |
5409471 | Atkinson et al. | Apr 1995 | A |
5417672 | Nita et al. | May 1995 | A |
5417673 | Gordon | May 1995 | A |
5437646 | Hunt et al. | Aug 1995 | A |
5439451 | Collinson et al. | Aug 1995 | A |
5441486 | Yoon | Aug 1995 | A |
5441487 | Vedder | Aug 1995 | A |
5445630 | Richmond | Aug 1995 | A |
5453097 | Paradis | Sep 1995 | A |
5456284 | Ryan et al. | Oct 1995 | A |
5456675 | Wolbring et al. | Oct 1995 | A |
5458640 | Gerrone | Oct 1995 | A |
5462255 | Rosen et al. | Oct 1995 | A |
5465938 | Werge et al. | Nov 1995 | A |
5466219 | Lynn et al. | Nov 1995 | A |
5470319 | Mayer | Nov 1995 | A |
5474536 | Bonaldo | Dec 1995 | A |
5474541 | Ritsky et al. | Dec 1995 | A |
5474544 | Lynn | Dec 1995 | A |
5487728 | Vaillancourt | Jan 1996 | A |
5487731 | Denton | Jan 1996 | A |
5492147 | Challender et al. | Feb 1996 | A |
5492304 | Smith et al. | Feb 1996 | A |
5501426 | Atkinson et al. | Mar 1996 | A |
5509433 | Paradis | Apr 1996 | A |
5509912 | Vaillancourt et al. | Apr 1996 | A |
5514098 | Pfoslgraf et al. | May 1996 | A |
5514116 | Vaillancourt et al. | May 1996 | A |
5529278 | Weldon et al. | Jun 1996 | A |
5531810 | Fullemann | Jul 1996 | A |
5533708 | Atkinson et al. | Jul 1996 | A |
5533983 | Haining | Jul 1996 | A |
5535771 | Purdy et al. | Jul 1996 | A |
5535785 | Werge et al. | Jul 1996 | A |
5540661 | Tomisaka et al. | Jul 1996 | A |
5549566 | Elias et al. | Aug 1996 | A |
5549577 | Siegel et al. | Aug 1996 | A |
5549651 | Lynn | Aug 1996 | A |
5552118 | Mayer | Sep 1996 | A |
5555908 | Edwards et al. | Sep 1996 | A |
5556388 | Johlin, Jr. | Sep 1996 | A |
5569235 | Ross et al. | Oct 1996 | A |
5573516 | Tyner | Nov 1996 | A |
5578059 | Patzer | Nov 1996 | A |
5584808 | Healy | Dec 1996 | A |
5597536 | Mayer | Jan 1997 | A |
5616130 | Mayer | Apr 1997 | A |
5620434 | Brony et al. | Apr 1997 | A |
5674206 | Alton et al. | Oct 1997 | A |
5685866 | Lopez | Nov 1997 | A |
5688254 | Lopez et al. | Nov 1997 | A |
5690612 | Lopez et al. | Nov 1997 | A |
5694686 | Lopez | Dec 1997 | A |
5695466 | Lopez et al. | Dec 1997 | A |
5699821 | Paradis | Dec 1997 | A |
5700248 | Lopez | Dec 1997 | A |
5702019 | Grimard | Dec 1997 | A |
5727770 | Dennis | Mar 1998 | A |
5738663 | Lopez | Apr 1998 | A |
5749861 | Guala et al. | May 1998 | A |
5776113 | Daugherty et al. | Jul 1998 | A |
5788675 | Mayer | Aug 1998 | A |
5820601 | Mayer | Oct 1998 | A |
5836923 | Mayer | Nov 1998 | A |
Number | Date | Country |
---|---|---|
2083670 | May 1993 | CA |
2907-832 | Sep 1980 | DE |
30 31 242 | Mar 1982 | DE |
30 42 229 | May 1982 | DE |
32 42 870 | Jun 1983 | DE |
33 03 718 | Oct 1984 | DE |
KLASSE A 61 | Oct 1985 | DE |
37 37 665 | Nov 1987 | DE |
38 09 127 | Mar 1988 | DE |
0 051 718 | May 1982 | EP |
0 111 723 | Nov 1983 | EP |
0 223 451 | May 1987 | EP |
0 309 771 | Apr 1989 | EP |
0 343 953 | Nov 1989 | EP |
0 414 997 | Mar 1991 | EP |
0 696 460 | Feb 1996 | EP |
0 696 461 | Feb 1996 | EP |
0 798 013 | Jan 1997 | EP |
0 811 560 | Dec 1997 | EP |
1.149.727 | Dec 1957 | FR |
2049513 | Mar 1971 | FR |
2 337 670 | Jan 1976 | FR |
2 012 919 | Aug 1979 | GB |
1634-936 | Mar 1991 | SU |
WO 8801881 | Mar 1988 | WO |
WO 8906553 | Jul 1989 | WO |
WO 9011103 | Oct 1990 | WO |
WO 9204936 | Apr 1992 | WO |
PCTUS9106604 | Jun 1992 | WO |
WO 9311828 | Jun 1993 | WO |
9324174 | Dec 1993 | WO |
WO 9600053 | Jan 1996 | WO |
WO 9640359 | Dec 1996 | WO |
WO 9700702 | Jan 1997 | WO |
WO 9721463 | Jun 1997 | WO |
WO 9724548 | Jul 1997 | WO |
WO 9738744 | Oct 1997 | WO |
WO 9817192 | Jan 1998 | WO |
WO 9850106 | Apr 1998 | WO |
WO 9823313 | Jun 1998 | WO |
WO 9826835 | Jun 1998 | WO |
Number | Date | Country | |
---|---|---|---|
60047161 | May 1997 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09081728 | May 1998 | US |
Child | 09370864 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09370864 | Aug 1999 | US |
Child | 10730772 | US |